PCN94 Cost-Effectiveness of Trifluridine/Tipiracil (FTD/TPI) As a Third-LINE Treatment of Metastatic Gastric Cancer, Including Adenocarcinoma of the Gastroesophageal Junction, Among Patients WHO Have Received at Least Two PRIOR Therapies for Metastatic Disease in Greece

Saved in:
Bibliographic Details
Published in:Value in health 2020-12, Vol.23, p.S439-S439
Main Authors: Gourzoulidis, G., Koulentaki, M., Koumarianou, A., Samantas, E., Androulakis, N., Xynogalos, S., Papakotoulas, P., Boukovinas, I., Karamouzis, M., Souglakos, I., Chotzagiannoglou, V., Beletsi, A., Kourlaba, G.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2020.08.231